Sterilucent Leadership Team
David C. Bell
Founder, President and Chief Executive Officer
Over 40 years of worldwide experience in leading and managing the development of new technologies and products and bringing them successfully to the market. Wealth of experience in identifying emerging and disruptive technologies, creating novel pathways to development, building teams and management capabilities to create new products, and attracting capital to bring his vision to life. Bachelor of Arts degree in Political Science and Business from Concordia College in Moorhead, Minnesota (graduated summa cum laude).
Chief Operating Officer
30 years of experience developing, launching and selling medical technologies for Johnson and Johnson, Sanofi, Medtronic, and as a startup CEO for seven years, spanning product development, manufacturing, sales, and marketing, and general management. Direct leadership in development and launch of significant products and systems. Served as CEO and launched Rapid Diagnostek, Rapid acquired by Qorvo, a $2.2 billion semiconductor company. Graduated from The University of Texas at Austin, McCombs School of Business.
Director of Clinical, Regulatory and Microbiology
Worked in sterilization, medical devices and medical device reprocessors for over 20 years at leading companies including STERIS R&D and Richard Wolf Medical. Led teams in multiple ISO 13485 certifications, prepared multiple 510k submissions leading to regulatory approvals, and maintained global registrations. Deep experience and knowledge of sterilization and surgical endoscopes. Worked across multiple medical device types and reprocessing methods, with experience in development, regulatory, quality, sales, and technical training. BS in Microbiology with a minor in Chemistry from Gannon University in Pennsylvania.